Intergroupe Francophone De Cancerologie Thoracique

This study tests whether adding an experimental immunotherapy (fianlimab) to standard immunotherapy (cemiplimab) plus chemotherapy can help control pleural mesothelioma, a rare and aggressive lung cancer. About 126 people who have not yet been treated will receive one of two trea…

This study is for people with advanced non-small cell lung cancer who also have interstitial lung disease (ILD), a condition that causes lung scarring. Many doctors are unsure how to treat these patients because standard cancer therapies can worsen ILD. The trial will test two ap…